Drug Information

Drug General Information
Drug ID
D02SPX
Former ID
DCL000540
Drug Name
IDX899
Drug Type
Small molecular drug
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Phase 2 [548635]
Company
GSK
Formula
C20H17ClN3O3P
Canonical SMILES
CC1=CC(=CC(=C1)C=CC#N)P(=O)(C2=C(NC3=C2C=C(C=C3)Cl)C(=O<br />)N)OC
InChI
1S/C20H17ClN3O3P/c1-12-8-13(4-3-7-22)10-15(9-12)28(26,27-2)19-16-11-14(21)5-6-17(16)24-18(19)20(23)25/h3-6,8-11,24H,1-2H3,(H2,23,25)/b4-3+/t28-/m1/s1
InChIKey
CGBYTKOSZYQOPV-ASSBYYIWSA-N
PubChem Compound ID
44232529
PubChem Substance ID
103033138, 120086733, 123055415, 134339113, 135626649, 141763696, 160692601, 227286080
Target and Pathway
Target(s) HIV reverse transcriptase Target Info Modulator
References
Ref 548635Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027243)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.